A low m1A score is associated with a high neoantigen burden, which leads to increased proliferation of cluster of differentiation (CD)8 + T effector cells, enhanced responses to anti-PD-L1 immunotherapy, and prolonged survival in colon cancer [47]. The gene discussed is CD274; the disease is malignant colon neoplasm.